Congratulations to Two Myocarditis Researchers Affiliated with the Myocarditis Foundation!

Mayo Clinic recently received  26 million dollars from BARDA, (Biomedical Advanced Research and Development Authority) for the COVID-19 Convalescent Plasma Expanded Access Program.

Dr. DeLisa Fairweather and Dr. Katelyn Bruno have been working tirelessly, 24/7, on this project which is aimed at fighting the COVID-19 Virus.

Dr. Fairweather, a member of the Myocarditis Foundation Medical Advisory Board, is a co-investigator on the study and Dr. Bruno, a member of Dr. Fairweather’s lab at Mayo Clinic, Jacksonville Florida is the co-chair of the Data Management Committee and both are part of the Oversight Committee Expanded Access Program.

 

https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-receives-26-million-from-barda-for-covid-19-convalescent-plasma-expanded-access-program/?utm_source=facebook&utm_medium=sm&utm_content=post&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&mc_id=us&cauid=100502&linkId=87962111&fbclid=IwAR23rS_3nKjXsU3GHcrXzSdmix7VjPPqwk9OJMbwWrsdes-u-hmgzBA6a0Q